You have 8 free searches left this month | for more free features.

Tumor necrosis factor-α (TNF-α)

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Rheumatoid Arthritis Trial in Canada, United States (ISIS 104838)

Completed
  • Rheumatoid Arthritis
  • ISIS 104838
  • Birmingham, Alabama
  • +30 more
Dec 1, 2022

Role of Inflammation in Carpal Tunnel Syndrome

Not yet recruiting
  • Carpal Tunnel Syndrome
  • Median Neuropathy, Carpal Tunnel
  • Inflammatory markers
  • Al Ḩayy Ath Thāmin, Giza, Egypt
    Outpatient clinic of faculty of physical therapy, Ahram Canadian
May 1, 2023

Obstructive Sleep Apnea Trial in Assiut (adenotonsillectomy, Lifestyle intervention)

Completed
  • Obstructive Sleep Apnea
  • adenotonsillectomy
  • Lifestyle intervention
  • Assiut, Egypt
    Al-Azhar University
Jun 13, 2022

Ustekinumab in Active Crohn's Disease

Completed
  • Crohn Disease
  • Evaluation of biological predictive factors of clinical response to ustekinumab
  • Pierre-Bénite, France
    Centre hospitalier Lyon Sud
Aug 23, 2022

Periapical Periodontitis, MMP-9 Trial in Istanbul (apical periodontitis)

Completed
  • Periapical Periodontitis
  • MMP-9
  • apical periodontitis
  • Istanbul, Esenler, Turkey
    Istanbul Medipol University, Faculty of Dentistry
May 4, 2023

Spinal Stenosis Trial (Epidural Intervention with TNF-a inhibitor)

Completed
  • Spinal Stenosis
  • Epidural Intervention with TNF-α inhibitor
  • (no location specified)
Aug 19, 2019

Non Small Cell Lung Cancer Trial in Istanbul (LW-02 device immunopheresis combined with atezolizumab, LW-02 device

Recruiting
  • Non Small Cell Lung Cancer
  • LW-02 device immunopheresis combined with atezolizumab
  • +2 more
  • Istanbul, Kucukcekmece, Turkey
  • +2 more
Mar 6, 2022

Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy, Retinal Detachment Trial in Cairo (Intravitreal infliximab,

Recruiting
  • Rhegmatogenous Retinal Detachment
  • +2 more
  • Intravitreal infliximab
  • Pars plana vitrectomy
  • Cairo, Egypt
    Cairo University
Nov 26, 2021

Warts Trial in Zagazig (Candida antigen)

Completed
  • Warts
  • Candida antigen
  • Zagazig, Sharqia, Egypt
    Zagazig University Faculty of Medicine
May 24, 2020

Salivary Interleukin-32, Interleukin-10, Interleukin-6 and Tumor

Completed
  • Early Childhood Caries
  • ELISA
  • Aydın, Turkey
    Sultan KELEŞ
Oct 20, 2021

Atrial Fibrillation Trial in Tanta (Measuring Serum bio-markers)

Completed
  • Atrial Fibrillation
  • Measuring Serum bio-markers
  • Tanta, Egypt
    Tanta university
Nov 5, 2021

Menopause Trial in Shatin (Modified Guizhi Fuling granules, Placebo)

Not yet recruiting
  • Menopause
  • Modified Guizhi Fuling granules
  • Placebo
  • Shatin, Hong Kong
    School of Chinese Medicine
Oct 4, 2023

Rheumatoid Arthritis Trial (ABT-494, Placebo)

Completed
  • Rheumatoid Arthritis
  • (no location specified)
Jul 29, 2021

Multiple Sclerosis Trial in Giza ("RehaCom" computer-based cognitive training in addition to Conventional physical therapy

Completed
  • Multiple Sclerosis
  • "RehaCom" computer-based cognitive training in addition to Conventional physical therapy program
  • Conventional physical therapy program
  • Giza, Dokki, Egypt
    Faculty of physical therapy, Cairo University
Jan 2, 2022

Rheumatoid Arthritis Disease Activity and Sub Clinical

Completed
  • Rheumatoid Arthritis
    • Assiut, Egypt
      Assiut university hospital
    Jan 23, 2023

    Frailty Trial in Nassau (Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))

    Recruiting
    • Frailty
    • Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
    • Nassau, The Bahamas, Bahamas
      The Partners Clinical Research Centre at The Medical Pavilion
    Oct 2, 2023

    Sarcopenia Trial in New Taipei City (HINEX Jelly ( jelly high protein supplement))

    Active, not recruiting
    • Sarcopenia
    • HINEX Jelly ( jelly high protein supplement)
    • New Taipei City, Zhonghe Dist., Taiwan
      Taipei Medical University
    Jun 28, 2023

    Laparoscopic Gastrectomy, Ropivacaine Trial in Guangzhou (0.5% Ropivacaine, Saline)

    Not yet recruiting
    • Laparoscopic Gastrectomy
    • Ropivacaine
    • Guangzhou, Guangdong, China
      SanQing Jin
    Nov 23, 2023

    Metabolic Syndrome Trial in Banja Luka (Polyphenols of pomegranate fruit peel extract (PoPex), Placebo)

    Active, not recruiting
    • Metabolic Syndrome
    • Polyphenols of pomegranate fruit peel extract (PoPex)
    • Placebo
    • Banja Luka, Republic Of Srpska, Bosnia and Herzegovina
      Public Health Institution Dom zdravlja Banja Luka
    Jun 13, 2023

    Influenza, COVID-19, RSV Infection Trial (Collection of saliva, nasopharyngeal-, nasal-, and oropharyngeal swabs)

    Not yet recruiting
    • Influenza
    • +2 more
    • Collection of saliva, nasopharyngeal-, nasal-, and oropharyngeal swabs
    • (no location specified)
    Mar 1, 2023

    Mild Cognitive Impairment (MCI), Alzheimer, Dementia Trial (XPro1595, Placebo)

    Not yet recruiting
    • Mild Cognitive Impairment (MCI)
    • +8 more
    • (no location specified)
    Aug 16, 2022

    Hand and Foot Syndrome, Erythrodysesthesia Syndrome, HFS Trial in Tanta (Celecoxib 200mg, Capecitabine-based chemo)

    Recruiting
    • Hand and Foot Syndrome
    • +3 more
    • Celecoxib 200mg
    • Capecitabine-based chemotherapy
    • Tanta, Egypt
      Faculty of Pharmacy-Tanta University
    Apr 7, 2022

    Can Saliva be New Bio-fluid to Monitor Children's Oral Health?

    Completed
    • Healthy
      • Jerusalem, Israel
        Hadassah Medical Organization, Jerusalem, Israel
      Aug 8, 2022

      Aneurysm, Cerebral Trial in Zagreb (Lidocaine)

      Unknown status
      • Aneurysm, Cerebral
      • Zagreb, Croatia
        UHCZagreb
      Nov 10, 2020

      Cardiopulmonary Trial (Plants placed in an office environment, Devoid of any plant presence in an office environment)

      Not yet recruiting
      • Cardiopulmonary
      • Plants placed in an office environment
      • Devoid of any plant presence in an office environment
      • (no location specified)
      Oct 2, 2023